MF · holdings as filed 2026-04-30

What's inside AHSAX?

ALGER HEALTH SCIENCES FUND
Holdings
59
positions in the fund
Top 10
36%
of fund assets
Expense ratio
1.17%
net, per year
Fund size
$61M
total net assets
Top 15 holdings
1
IMPULSE DYNAMICS IRELAND
4.88%
2
TEVATEVA PHARMACEUTICAL-SP ADR
4.58%
3
FBRXFORTE BIOSCIENCES INC
4.28%
4
ARWRARROWHEAD PHARMACEUTICALS IN
4.04%
5
WELLWELLTOWER INC
3.23%
6
CAHCARDINAL HEALTH INC
3.22%
7
JNJJOHNSON & JOHNSON
2.99%
8
TWSTTWIST BIOSCIENCE CORP
2.93%
9
MRKMERCK & CO. INC.
2.88%
10
NKTRNEKTAR THERAPEUTICS
2.66%
11
CTVACORTEVA INC
2.55%
12
ROIVROIVANT SCIENCES LTD
2.54%
13
GILDGILEAD SCIENCES INC
2.39%
14
SYRESPYRE THERAPEUTICS INC
2.32%
15
CVSCVS HEALTH CORP
2.25%
Sectors
1Health Care
74%
2Financials
9%
3Unclassified
8%
4Industrials
3%
5Materials
3%
6Consumer Discretionary
2%
Geography
1United States
86%
2Unclassified
5%
3United Kingdom
4%
4Bermuda
3%
5Switzerland
2%
Hold AHSAX alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings (as of 2026-04-30); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.